Parenteral Drugs (India) (NSE:PDPL) Book Value per Share: ₹-276.37 (As of Mar. 2022)

Parenteral Drugs (India)  (NSE:PDPL) Book Value per Share Explanation

Usually a company's book value and Tangible Book per Share may not reflect its true value. The assets may be carried on the balance sheets at the original cost minus depreciation. This may underestimate the true economic values of the assets. It also may over-estimate their true economic value because the assets can become obsolete.

For financial companies such as banks and insurance companies, their assets may be reported in current market value of the assets owned. Book values of financial companies are more accurate indicator of the economic value of the company.

Parenteral Drugs (India) Book Value per Share Related Terms

The historical data trend for Parenteral Drugs (India)'s Book Value per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Parenteral Drugs (India) Book Value per Share Chart

Parenteral Drugs (India) Annual Data
	Trend	Mar13	Mar14	Mar15	Mar16	Mar17	Mar18	Mar19	Mar20	Mar21	Mar22
Book Value per Share		Get a 7-Day Free Trial					-45.76	-149.89	-188.26	-229.03	-276.37

Parenteral Drugs (India) Quarterly Data
	Jun17	Sep17	Dec17	Mar18	Jun18	Sep18	Dec18	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22
Book Value per Share	Get a 7-Day Free Trial															-229.03	0.00	-251.04	0.00	-276.37

NSE:PDPL vs ZTS, CTLT, VTRS: Book Value per Share Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Parenteral Drugs (India)'s PB Ratio, along with its competitors' market caps and PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Parenteral Drugs (India) PB Ratio vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Parenteral Drugs (India)'s PB Ratio distribution charts can be found below:

* The bar in red indicates where Parenteral Drugs (India)'s PB Ratio falls into.

Parenteral Drugs (India) Book Value per Share Calculation

Parenteral Drugs (India)'s Book Value Per Share for the fiscal year that ended in Mar. 2022 is calculated as:

Parenteral Drugs (India)'s Book Value Per Share for the quarter that ended in Mar. 2022 is calculated as:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Theoretically it is what the shareholders will receive if the company is liquidated. Total Stockholders Equity is a balance sheet item and equal to Total Assets less Total Liabilities of the company.

Book value may include intangible items which may come from the company's past acquisitions. Book value less intangibles is called Tangible Book.

Parenteral Drugs (India) Business Description